{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:45:07Z","timestamp":1792025107811,"version":"4.4.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Federal Chancellery of the Federal Republic of Germany"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recent studies have demonstrated that dermal exposure to anabolic androgenic steroids (AAS) can result in adverse analytical findings (AAFs) in doping controls with a comparably long detectability of the parent compound and\/or their metabolites in urine samples. Transdermal absorption is influenced by multiple factors, including physicochemical properties of the substance and solubility; but is largely driven by the degree of exposure, i.e. amount of substance applied. Therefore, this study aimed to investigate the detectability and urinary excretion profiles of trenbolone (TREN) and metenolone (MET) after dermal exposure to microgram quantities of these frequently abused AAS. Controlled excretion studies were conducted with healthy male volunteers, and each participant received a single dose of 50\u2009\u00b5g TREN or MET via dermal application to the forearm. Urine samples were collected and analyzed for the parent compounds and their metabolites by liquid chromatography coupled to high resolution tandem mass spectrometry (LC\u2013HRMS\/MS). To enhance sensitivity and product ion formation, derivatization with Girard\u2019s reagent T was employed for MET and its metabolites. Following administration of transdermal microdoses, both substances and\/or their metabolites were detectable in the urine samples of all participants. For TREN, predominantly the established main metabolite epitrenbolone was identified, with maximum concentrations up to 2.6\u2009ng\/ml and a detection window of up to 3 days post-application. Maximum concentrations of MET ranged from 0.1 to 1.2\u2009ng\/ml. Notably, particularly the sulfoconjugated metabolite of MET remained detectable for over a week in one volunteer. Metabolite profiles were compared with those of urine samples obtained after oral administration of the steroids to assess potential differences. Considering the increasing number of alleged transdermal contamination cases, the results provide important analytical data to better assess the plausibility of such claims.<\/jats:p>","DOI":"10.1093\/jat\/bkag085","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:17:36Z","timestamp":1789672656000},"source":"Crossref","is-referenced-by-count":0,"title":["Urinary detection and metabolite profiles of trenbolone and metenolone following trace-level dermal exposure"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0373-3715","authenticated-orcid":false,"given":"Sophia","family":"Krombholz","sequence":"first","affiliation":[{"name":"Institute of Biochemistry, Center for Preventive Doping Research, German Sport University Cologne , Cologne, 50933,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiannis A","family":"Angelis","sequence":"additional","affiliation":[{"name":"National Center for Scientific Research \u201cDemokritos\u201d\u2014Doping Control Laboratory of Athens, Institute of Biosciences & Applications , 153 41 Athens,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Fu\u00dfh\u00f6ller","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Center for Preventive Doping Research, German Sport University Cologne , Cologne, 50933,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5972-8854","authenticated-orcid":false,"given":"Mario","family":"Thevis","sequence":"additional","affiliation":[{"name":"Institute of Biochemistry, Center for Preventive Doping Research, German Sport University Cologne , Cologne, 50933,","place":["Germany"]},{"name":"European Center for Emerging Doping Agents, Cologne, 50933,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"2026101419594255700_bkag085-B1","author":"World Anti-Doping Agency","year":"2021"},{"key":"2026101419594255700_bkag085-B2","author":"Federal Ministry of Justice and Consumer Protection","year":"2015"},{"key":"2026101419594255700_bkag085-B3","doi-asserted-by":"publisher","first-page":"100412","DOI":"10.1016\/j.peh.2025.100412","article-title":"Talking dirty: Anti-doping\u2019s stigmatizing rhetoric and its impact on the unintentional doper","volume":"14","author":"Grimes","year":"2026","journal-title":"Perform Enhanc Health"},{"key":"2026101419594255700_bkag085-B4","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1002\/dta.70033","article-title":"Annual banned-substance review 18th edition-analytical approaches in human sports drug testing 2024\/2025","volume":"18","author":"Thevis","year":"2026","journal-title":"Drug Test Anal"},{"key":"2026101419594255700_bkag085-B5","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1515\/jpem-2020-0616","article-title":"Precocious sexual development in a male toddler caused by unrecognized transdermal exposure to testosterone: case report and review of the literature","volume":"34","author":"Azova","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2026101419594255700_bkag085-B6","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1002\/dta.2951","article-title":"Detection of clostebol in sports: accidental doping?","volume":"12","author":"de la Torre","year":"2020","journal-title":"Drug Test Anal"},{"key":"2026101419594255700_bkag085-B7","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1002\/dta.3355","article-title":"Detectability of oxandrolone, metandienone, clostebol and dehydrochloromethyltestosterone in urine after transdermal application","volume":"14","author":"Gessner","year":"2022","journal-title":"Drug Test Anal"},{"key":"2026101419594255700_bkag085-B8","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4419-7615-4_3","article-title":"Illicit drugs: contaminants in the environment and utility in forensic epidemiology","volume":"210","author":"Daughton","year":"2011","journal-title":"Rev Environ Contam Toxicol"},{"key":"2026101419594255700_bkag085-B9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1515\/jpem-2022-0521","article-title":"Sexual precocity in the setting of parental use of a compounded testosterone cream: case report and review of the literature","volume":"36","author":"Georges","year":"2023","journal-title":"J Pediatr Endocrinol Metab"},{"key":"2026101419594255700_bkag085-B10","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.4158\/EP.14.8.1027","article-title":"Sexual precocity in a 2-year-old boy caused by indirect exposure to testosterone cream","volume":"14","author":"Stephen","year":"2008","journal-title":"Endocr Pract"},{"key":"2026101419594255700_bkag085-B11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40257-019-00480-4","article-title":"Twenty clinically pertinent factors\/observations for percutaneous absorption in humans","volume":"21","author":"Law","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"2026101419594255700_bkag085-B12","first-page":"89","article-title":"A new transdermal delivery system for estradiol","volume":"2","author":"Good","year":"1985","journal-title":"JCR"},{"key":"2026101419594255700_bkag085-B13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s00345-003-0368-6","article-title":"Transdermal testosterone delivery: testosterone patch and gel","volume":"21","author":"Gooren","year":"2003","journal-title":"World J Urol"},{"key":"2026101419594255700_bkag085-B14","volume-title":"Exposure Factors Handbook: 2011 Edition","author":"(EPA). USEPA","year":"2011"},{"key":"2026101419594255700_bkag085-B15","doi-asserted-by":"publisher","first-page":"119688","DOI":"10.1016\/j.cca.2024.119688","article-title":"Evidence of ostarine cross-contamination via sweat in 2 athletes sharing the same neoprene hamstring sleeves. An original situation of drug transfer where the anti-doping rule violation was suspended by the sport authorities","volume":"559","author":"Kintz","year":"2024","journal-title":"Clin Chim Acta"},{"key":"2026101419594255700_bkag085-B16","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26041032","article-title":"Medicinal use of testosterone and related steroids revisited","volume":"26","author":"Tauchen","year":"2021","journal-title":"Molecules"},{"key":"2026101419594255700_bkag085-B17","doi-asserted-by":"publisher","first-page":"114312","DOI":"10.1016\/j.jpba.2021.114312","article-title":"Recent advances in identifying and utilizing metabolites of selected doping agents in human sports drug testing","volume":"205","author":"Thevis","year":"2021","journal-title":"J Pharm Biomed Anal"},{"key":"2026101419594255700_bkag085-B18","doi-asserted-by":"publisher","first-page":"339661","DOI":"10.1016\/j.aca.2022.339661","article-title":"Assessing human urinary clomiphene metabolites after consumption of eggs from clomiphene-treated laying hens using chromatographic-mass spectrometric approaches","volume":"1202","author":"Euler","year":"2022","journal-title":"Anal Chim Acta"},{"key":"2026101419594255700_bkag085-B19","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00216-021-03740-7","article-title":"Investigations into the elimination profiles and metabolite ratios of micro-dosed selective androgen receptor modulator LGD-4033 for doping control purposes","volume":"414","author":"Wagener","year":"2022","journal-title":"Anal Bioanal Chem"},{"key":"2026101419594255700_bkag085-B20","volume-title":"Recent Advances in Doping Analysis","author":"Geyer","year":"2007"},{"key":"2026101419594255700_bkag085-B21","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1210\/clinem\/dgad085","article-title":"Longitudinal profiling of endogenous steroids in blood using the athlete biological passport approach","volume":"108","author":"Equey","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026101419594255700_bkag085-B22","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/dta.2341","article-title":"Sensitivity of doping biomarkers after administration of a single dose testosterone gel","volume":"10","author":"Mullen","year":"2018","journal-title":"Drug Test Anal"},{"key":"2026101419594255700_bkag085-B23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/dta.3962","article-title":"Distinguishing between oral and transdermal administration routes of methyltestosterone through human urine and dried blood spot analyses for doping control purposes","volume":"18","author":"Okano","year":"2026","journal-title":"Drug Test Anal"},{"key":"2026101419594255700_bkag085-B24","doi-asserted-by":"publisher","first-page":"109716","DOI":"10.1016\/j.steroids.2025.109716","article-title":"The influence of the route of drug administration on the metabolic profile of trenbolone in doping control urine samples","volume":"225","author":"Krombholz","year":"2026","journal-title":"Steroids"},{"key":"2026101419594255700_bkag085-B25","author":"World Anti-Doping Agency","year":"2025"},{"key":"2026101419594255700_bkag085-B26","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/dta.3481","article-title":"Detection time comparison of non-hydrolysed sulphated metabolites of metenolone, mesterolone and 17alpha-methyltestosterone analysed by four different mass spectrometric techniques","volume":"15","author":"Albertsdottir","year":"2023","journal-title":"Drug Test Anal"},{"key":"2026101419594255700_bkag085-B27","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1002\/jms.3583","article-title":"Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS","volume":"50","author":"Fragkaki","year":"2015","journal-title":"J Mass Spectrom"},{"key":"2026101419594255700_bkag085-B28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.toxlet.2012.07.020","article-title":"Unexpected contribution of cytochrome P450 enzymes CYP11B2 and CYP21, as well as CYP3A4 in xenobiotic androgen elimination \u2013 insights from metandienone metabolism","volume":"213","author":"Parr","year":"2012","journal-title":"Toxicol Lett"},{"key":"2026101419594255700_bkag085-B29","author":"World Anti-Doping Agency","year":"2021"},{"key":"2026101419594255700_bkag085-B30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/dta.3465","article-title":"LC-MS\/(MS) confirmatory doping control analysis of intact phase II metabolites of methenolone and mesterolone after Girard\u2019s Reagent T derivatization","volume":"15","author":"Angelis","year":"2023","journal-title":"Drug Test Anal"},{"key":"2026101419594255700_bkag085-B31","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/dta.2818","article-title":"Searching for new long-term urinary metabolites of metenolone and drostanolone using gas chromatography-mass spectrometry with a focus on non-hydrolysed sulfates","volume":"12","author":"Albertsdottir","year":"2020","journal-title":"Drug Test Anal"},{"key":"2026101419594255700_bkag085-B32","volume-title":"Detection of New Long-Term Metabolites for Doping Analyses","author":"Coppieters","year":"2018"},{"key":"2026101419594255700_bkag085-B33","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3389\/fchem.2020.00435","article-title":"Identification of trenbolone metabolites using hydrogen isotope ratio mass spectrometry and liquid chromatography\/high accuracy\/high resolution mass spectrometry for doping control analysis","volume":"8","author":"Putz","year":"2020","journal-title":"Front Chem"},{"key":"2026101419594255700_bkag085-B34","doi-asserted-by":"publisher","first-page":"e04873","DOI":"10.2903\/j.efsa.2017.4873","article-title":"Guidance on dermal absorption","volume":"15","author":"Buist","year":"2017","journal-title":"EFSA J"},{"key":"2026101419594255700_bkag085-B35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/jat\/bkaf066","article-title":"Exploring transdermal SARMs exposure: analysis of the elimination profiles and metabolism for doping control purposes","volume":"49","author":"Korsmeier","year":"2025","journal-title":"J Anal Toxicol"},{"key":"2026101419594255700_bkag085-B36","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1007\/s11095-006-9108-0","article-title":"Design for optimized topical delivery: prodrugs and a paradigm change","volume":"23","author":"Sloan","year":"2006","journal-title":"Pharm Res"},{"key":"2026101419594255700_bkag085-B37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1211\/0022357001774101","article-title":"Skin permeation of testosterone and its ester derivatives in rats","volume":"52","author":"Kim","year":"2000","journal-title":"J Pharm Pharmacol"},{"key":"2026101419594255700_bkag085-B38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ejpb.2015.02.015","article-title":"Transdermal delivery of testosterone","volume":"92","author":"Hadgraft","year":"2015","journal-title":"Eur J Pharm Biopharm"},{"key":"2026101419594255700_bkag085-B39","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2147\/CPAA.S64788","article-title":"Skin models for the testing of transdermal drugs","volume":"8","author":"Abd","year":"2016","journal-title":"Clin Pharmacol"},{"key":"2026101419594255700_bkag085-B40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jat.4542","article-title":"Suitability of different reconstructed human skin models in the skin and liver Chip2 microphysiological model to investigate the kinetics and first-pass skin metabolism of the hair dye, 4-amino-2-hydroxytoluene","volume":"44","author":"Brandmair","year":"2024","journal-title":"J Appl Toxicol"},{"key":"2026101419594255700_bkag085-B41","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1021\/acs.jcim.8b00934","article-title":"Predicting skin permeability by means of computational approaches: reliability and caveats in pharmaceutical studies","volume":"59","author":"Pecoraro","year":"2019","journal-title":"J Chem Inf Model"},{"key":"2026101419594255700_bkag085-B42","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1002\/dta.3187","article-title":"Sports drug testing and the athletes\u2019 exposome","volume":"13","author":"Thevis","year":"2021","journal-title":"Drug Test Anal"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jat\/advance-article-pdf\/doi\/10.1093\/jat\/bkag085\/71225641\/bkag085.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/9\/bkag085\/71225641\/bkag085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jat\/article-pdf\/50\/9\/bkag085\/71225641\/bkag085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:59:51Z","timestamp":1792022391000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/doi\/10.1093\/jat\/bkag085\/8817216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":42,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,26]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bkag085","relation":{},"ISSN":["1945-2403"],"issn-type":[{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,9]]},"article-number":"bkag085"}}